Literature DB >> 20574627

Two cases of severe refractory chronic idiopathic urticaria treated with omalizumab.

Christian Vestergaard, Mette Deleuran.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20574627     DOI： 10.2340/00015555-0884

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN： 0001-5555            Impact factor:   4.437


× No keyword cloud information.
  11 in total

Review 1.  Benefits and Harms of Omalizumab Treatment in Adolescent and Adult Patients With Chronic Idiopathic (Spontaneous) Urticaria: A Meta-analysis of "Real-world" Evidence.

Authors:  Michael D Tharp; Jonathan A Bernstein; Abhishek Kavati; Benjamin Ortiz; Karen MacDonald; Kris Denhaerynck; Ivo Abraham; Christopher S Lee
Journal:  JAMA Dermatol       Date:  2019-01-01       Impact factor: 10.282

2.  Omalizumab for difficult-to-treat dermatological conditions: clinical and immunological features from a retrospective real-life experience.

Authors:  Ciro Romano; Ausilia Sellitto; Umberto De Fanis; Antonella Balestrieri; Alfonso Savoia; Salvatore Abbadessa; Corrado Astarita; Giacomo Lucivero
Journal:  Clin Drug Investig       Date:  2015-03       Impact factor: 2.859

Review 3.  Omalizumab: Anti-IgE therapy in allergy.

Authors:  Matthias Volkmar Kopp
Journal:  Curr Allergy Asthma Rep       Date:  2011-04       Impact factor: 4.806

4.  T cell activity in successful treatment of chronic urticaria with omalizumab.

Authors:  Inmaculada Sánchez-Machín; Javier Iglesias-Souto; Andrés Franco; Yvelise Barrios; Ruperto Gonzalez; Víctor Matheu
Journal:  Clin Mol Allergy       Date:  2011-07-26

5.  Omalizumab for chronic urticaria: a case series and overview of the literature.

Authors:  Ilya Ivyanskiy; Carsten Sand; Simon Francis Thomsen
Journal:  Case Rep Dermatol       Date:  2012-01-30

Review 6.  Role of biologics in intractable urticaria.

Authors:  Andrew Cooke; Adeeb Bulkhi; Thomas B Casale
Journal:  Biologics       Date:  2015-04-13

7.  Effectiveness of omalizumab in a patient with a life-threatening episode of bronchospasm and larynx angioedema after exposure to house dust.

Authors:  Izabela Kupryś-Lipińska; Paulina Korczyńska; Damian Tworek; Piotr Kuna
Journal:  Postepy Dermatol Alergol       Date:  2014-02-25       Impact factor: 1.837

Review 8.  Chronic urticaria: new management options.

Authors:  Paul A Greenberger
Journal:  World Allergy Organ J       Date:  2014-11-05       Impact factor: 4.084

9.  Diagnosis and treatment of urticaria and angioedema: a worldwide perspective.

Authors:  Mario Sánchez-Borges; Riccardo Asero; Ignacio J Ansotegui; Ilaria Baiardini; Jonathan A Bernstein; G Walter Canonica; Richard Gower; David A Kahn; Allen P Kaplan; Connie Katelaris; Marcus Maurer; Hae Sim Park; Paul Potter; Sarbjit Saini; Paolo Tassinari; Alberto Tedeschi; Young Min Ye; Torsten Zuberbier
Journal:  World Allergy Organ J       Date:  2012-11       Impact factor: 4.084

Review 10.  Profile of omalizumab in the treatment of chronic spontaneous urticaria.

Authors:  Moises Labrador-Horrillo; Marta Ferrer
Journal:  Drug Des Devel Ther       Date:  2015-08-25       Impact factor: 4.162
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.